also known nonsteroidal antiandrogen nsaa initially developed roussel uclaf french pharmaceutical company received name formerly investigation prostrakan previously proskelia strakan potential use topical treatment androgendependent conditions including acne pattern hair excessive hair compound similar structure nsaa contains different compounds similar chemical structure related flutamide bicalutamide enzalutamide nsaas synthesized either building hydantoin moiety aryl coupling produces cyanonilutamide metabolites cyanonilutamide relatively low affinity androgen receptor shows significant antiandrogenic activity low affinity androgen